Quest Diagnostics
DGX
#1067
Rank
โ‚น1.512 T
Marketcap
โ‚น13,553
Share price
2.30%
Change (1 day)
20.84%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2023 (TTM): โ‚น557.67

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น571.04. In 2022 the company made an earnings per share (EPS) of โ‚น680.86 a decrease over its 2021 EPS that were of โ‚น1,341.

EPS history for Quest Diagnostics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น557.67-18.09%
2022โ‚น680.86-49.21%
2021โ‚น1,34149.72%
2020โ‚น895.4266.67%
2019โ‚น537.2518%
2018โ‚น455.31-4.26%
2017โ‚น475.5923.19%
2016โ‚น386.05-7.11%
2015โ‚น415.6128.46%
2014โ‚น323.53-31.61%
2013โ‚น473.0560.46%
2012โ‚น294.81-16.51%
2011โ‚น353.102.45%
2010โ‚น344.654.35%
2009โ‚น330.2930.77%
2008โ‚น252.5868.93%
2007โ‚น149.52-40.6%
2006โ‚น251.739.96%
2005โ‚น228.9210.39%
2004โ‚น207.3816.35%
2003โ‚น178.2426.73%
2002โ‚น140.6590.29%
2001โ‚น73.9153.51%
2000โ‚น48.15-22900%
1999-โ‚น0.21-101.11%
1998โ‚น19.01-216.88%
1997-โ‚น16.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น635.24 11.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น28.81-105.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น77.72-113.61%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น79.41-113.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น122.84-78.49%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands